Comparisons of Quality of Life and Functional and Oncological Outcomes after Orthotopic Neobladder Reconstruction: Prostate-Sparing Cystectomy versus Conventional Radical Cystoprostatectomy
Table 1
Patient characteristics.
Patient characteristics
CRC† ()
PSC† ()
Age
57.5 ± 13.93
0.695
BMI†
23.85 ± 2.97
24.56 ± 4.71
0.695
ASA†
2.09
2.14
0.706
ECOG†
0.27
0.29
0.891
Neoadjuvant chemotherapy
1 (9%)
2 (14.3%)
1.000
Pathological stage:
<T2 N0
6 (54.5%)
5 (35.7%)
0.437
T2 or higher or N positive
5 (45.5%)
9 (64.2%)
0.351
Pathological grade:
Low grade or glandular cystitis
3 (27.2%)
2 (14.3%)
0.11
High grade
7 (64.6%)
12 (85.7%)
Numbers of patients with intact erectile function before surgery
7 (64.6%)
10 (71.4%)
IIEF-5† for intact erectile patients
23.9
23.9
0.956
IPSS†
8.6
12.6
0.34
Daytime continence (%)
11 (100%)
14 (100%)
—
Nighttime continence (%)
11 (100%)
14 (100%)
—
Need CIC†
0%
0%
—
Follow-up time (months)
73.82
51.14
(IQR† = 84)
(IQR† = 65)
, American Society of Anesthesiologists Physical Status classification; †ECOG, Eastern Cooperative Oncology Group Performance Status; †CRC, conventional radical cystoprostatectomy; †PSC, prostate-sparing cystectomy; †BMI, body mass index; IIEF, International Index of Erectile Function; †IPSS, International Prostate Symptom Score; †CIC, Clean Intermittent Catheterization; †IQR, Interquartile Range; .
